178 related articles for article (PubMed ID: 7650032)
1. An epidermal growth factor receptor-leukocyte tyrosine kinase chimeric receptor generates ligand-dependent growth signals through the Ras signaling pathway.
Ueno H; Hirano N; Kozutsumi H; Sasaki K; Tanaka T; Yazaki Y; Hirai H
J Biol Chem; 1995 Aug; 270(34):20135-42. PubMed ID: 7650032
[TBL] [Abstract][Full Text] [Related]
2. Growth and survival signals transmitted via two distinct NPXY motifs within leukocyte tyrosine kinase, an insulin receptor-related tyrosine kinase.
Ueno H; Sasaki K; Kozutsumi H; Miyagawa K; Mitani K; Yazaki Y; Hirai H
J Biol Chem; 1996 Nov; 271(44):27707-14. PubMed ID: 8910363
[TBL] [Abstract][Full Text] [Related]
3. Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase.
Fridell YW; Jin Y; Quilliam LA; Burchert A; McCloskey P; Spizz G; Varnum B; Der C; Liu ET
Mol Cell Biol; 1996 Jan; 16(1):135-45. PubMed ID: 8524290
[TBL] [Abstract][Full Text] [Related]
4. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
Besset V; Scott RP; Ibáñez CF
J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
[TBL] [Abstract][Full Text] [Related]
5. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.
Sasaoka T; Ishihara H; Sawa T; Ishiki M; Morioka H; Imamura T; Usui I; Takata Y; Kobayashi M
J Biol Chem; 1996 Aug; 271(33):20082-7. PubMed ID: 8702728
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent.
Gill K; Macdonald-Obermann JL; Pike LJ
J Biol Chem; 2017 Dec; 292(50):20744-20755. PubMed ID: 29074618
[TBL] [Abstract][Full Text] [Related]
7. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
[TBL] [Abstract][Full Text] [Related]
8. A Drosophila shc gene product is implicated in signaling by the DER receptor tyrosine kinase.
Lai KM; Olivier JP; Gish GD; Henkemeyer M; McGlade J; Pawson T
Mol Cell Biol; 1995 Sep; 15(9):4810-8. PubMed ID: 7651398
[TBL] [Abstract][Full Text] [Related]
9. An oncogenic epidermal growth factor receptor signals via a p21-activated kinase-caldesmon-myosin phosphotyrosine complex.
McManus MJ; Boerner JL; Danielsen AJ; Wang Z; Matsumura F; Maihle NJ
J Biol Chem; 2000 Nov; 275(45):35328-34. PubMed ID: 10954714
[TBL] [Abstract][Full Text] [Related]
10. Insulin and epidermal growth factor receptors regulate distinct pools of Grb2-SOS in the control of Ras activation.
Waters SB; Chen D; Kao AW; Okada S; Holt KH; Pessin JE
J Biol Chem; 1996 Jul; 271(30):18224-30. PubMed ID: 8663461
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of Shc protein and Shc-Grb2/ASH association and retains mitogenic activity.
Gotoh N; Tojo A; Muroya K; Hashimoto Y; Hattori S; Nakamura S; Takenawa T; Yazaki Y; Shibuya M
Proc Natl Acad Sci U S A; 1994 Jan; 91(1):167-71. PubMed ID: 7506413
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of SHIP-mediated inhibition of insulin- and platelet-derived growth factor-stimulated mitogen-activated protein kinase activity in 3T3-L1 adipocytes.
Sharma PM; Son HS; Ugi S; Ricketts W; Olefsky JM
Mol Endocrinol; 2005 Feb; 19(2):421-30. PubMed ID: 15486046
[TBL] [Abstract][Full Text] [Related]
13. Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.
Tauchi T; Boswell HS; Leibowitz D; Broxmeyer HE
J Exp Med; 1994 Jan; 179(1):167-75. PubMed ID: 7505797
[TBL] [Abstract][Full Text] [Related]
14. N-Shc: a neural-specific adapter molecule that mediates signaling from neurotrophin/Trk to Ras/MAPK pathway.
Nakamura T; Sanokawa R; Sasaki Y; Ayusawa D; Oishi M; Mori N
Oncogene; 1996 Sep; 13(6):1111-21. PubMed ID: 8808684
[TBL] [Abstract][Full Text] [Related]
15. Shc and a novel 89-kDa component couple to the Grb2-Sos complex in fibroblast growth factor-2-stimulated cells.
Klint P; Kanda S; Claesson-Welsh L
J Biol Chem; 1995 Oct; 270(40):23337-44. PubMed ID: 7559490
[TBL] [Abstract][Full Text] [Related]
16. Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon.
Piiper A; Elez R; You SJ; Kronenberger B; Loitsch S; Roche S; Zeuzem S
J Biol Chem; 2003 Feb; 278(9):7065-72. PubMed ID: 12496267
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine phosphorylation sites at amino acids 239 and 240 of Shc are involved in epidermal growth factor-induced mitogenic signaling that is distinct from Ras/mitogen-activated protein kinase activation.
Gotoh N; Toyoda M; Shibuya M
Mol Cell Biol; 1997 Apr; 17(4):1824-31. PubMed ID: 9121430
[TBL] [Abstract][Full Text] [Related]
18. Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites.
Fan YX; Wong L; Deb TB; Johnson GR
J Biol Chem; 2004 Sep; 279(37):38143-50. PubMed ID: 15231819
[TBL] [Abstract][Full Text] [Related]
19. Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway.
Prigent SA; Nagane M; Lin H; Huvar I; Boss GR; Feramisco JR; Cavenee WK; Huang HS
J Biol Chem; 1996 Oct; 271(41):25639-45. PubMed ID: 8810340
[TBL] [Abstract][Full Text] [Related]
20. Nerve growth factor induced stimulation of Ras requires Trk interaction with Shc but does not involve phosphoinositide 3-OH kinase.
Hallberg B; Ashcroft M; Loeb DM; Kaplan DR; Downward J
Oncogene; 1998 Aug; 17(6):691-7. PubMed ID: 9715270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
